Impact of cervical cancer screening guidelines on screening for chlamydia

Allison Ursu; Ananda Sen; Mack Ruffin

doi:10.1370/afm.1811

Impact of cervical cancer screening guidelines on screening for chlamydia

Allison Ursu, Ananda Sen, Mack Ruffin

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

The highest prevalence of chlamydia infection in the United States is among people aged 15 to 24 years. We assessed the impact of not doing routine cervical cancer screening on the rates of chlamydia screening in women aged 15 to 21 years. We classified visits to family medicine ambulatory clinics according to their timing relative to the 2009 guideline change that led to more restrictive cervical cancer screening. Women had higher odds of being screened for chlamydia before vs after the guideline change (odds ratio = 13.97; 95% CI, 9.17-21.29; P <.001). Chlamydia and cervical cancer screening need to be uncoupled and new screening opportunities should be identified.

Original language	English (US)
Pages (from-to)	361-363
Number of pages	3
Journal	Annals of family medicine
Volume	13
Issue number	4
DOIs	https://doi.org/10.1370/afm.1811
State	Published - Jan 1 2015

All Science Journal Classification (ASJC) codes

Family Practice

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1370/afm.1811

Cite this

@article{cf51136b84e3440a9b2c6cecf35fa1f1,

title = "Impact of cervical cancer screening guidelines on screening for chlamydia",

abstract = "The highest prevalence of chlamydia infection in the United States is among people aged 15 to 24 years. We assessed the impact of not doing routine cervical cancer screening on the rates of chlamydia screening in women aged 15 to 21 years. We classified visits to family medicine ambulatory clinics according to their timing relative to the 2009 guideline change that led to more restrictive cervical cancer screening. Women had higher odds of being screened for chlamydia before vs after the guideline change (odds ratio = 13.97; 95% CI, 9.17-21.29; P <.001). Chlamydia and cervical cancer screening need to be uncoupled and new screening opportunities should be identified.",

author = "Allison Ursu and Ananda Sen and Mack Ruffin",

year = "2015",

month = jan,

day = "1",

doi = "10.1370/afm.1811",

language = "English (US)",

volume = "13",

pages = "361--363",

journal = "Annals of family medicine",

issn = "1544-1709",

publisher = "Annals of Family Medicine, Inc",

number = "4",

}

TY - JOUR

T1 - Impact of cervical cancer screening guidelines on screening for chlamydia

AU - Ursu, Allison

AU - Sen, Ananda

AU - Ruffin, Mack

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The highest prevalence of chlamydia infection in the United States is among people aged 15 to 24 years. We assessed the impact of not doing routine cervical cancer screening on the rates of chlamydia screening in women aged 15 to 21 years. We classified visits to family medicine ambulatory clinics according to their timing relative to the 2009 guideline change that led to more restrictive cervical cancer screening. Women had higher odds of being screened for chlamydia before vs after the guideline change (odds ratio = 13.97; 95% CI, 9.17-21.29; P <.001). Chlamydia and cervical cancer screening need to be uncoupled and new screening opportunities should be identified.

AB - The highest prevalence of chlamydia infection in the United States is among people aged 15 to 24 years. We assessed the impact of not doing routine cervical cancer screening on the rates of chlamydia screening in women aged 15 to 21 years. We classified visits to family medicine ambulatory clinics according to their timing relative to the 2009 guideline change that led to more restrictive cervical cancer screening. Women had higher odds of being screened for chlamydia before vs after the guideline change (odds ratio = 13.97; 95% CI, 9.17-21.29; P <.001). Chlamydia and cervical cancer screening need to be uncoupled and new screening opportunities should be identified.

UR - http://www.scopus.com/inward/record.url?scp=84937843681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937843681&partnerID=8YFLogxK

U2 - 10.1370/afm.1811

DO - 10.1370/afm.1811

M3 - Article

C2 - 26195682

AN - SCOPUS:84937843681

SN - 1544-1709

VL - 13

SP - 361

EP - 363

JO - Annals of family medicine

JF - Annals of family medicine

IS - 4

ER -

Impact of cervical cancer screening guidelines on screening for chlamydia

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this